A global clinical trial shows GMRx2, a triple-pill blood pressure medication, reduces recurrent stroke risk by 40% in patients with intracerebral hemorrhage.
← News
Science Breakthroughs Science Breakthroughs Knowledge
Low-dose triple-pill cuts risk of recurrent stroke by about 40%, global trial shows
40% % Stroke risk reduction
3 Low-Dose Blood Pressure Medicines pill Medication combination
TRIDENT randomized controlle Trial name
New England Journal Of Medicine peer-reviewed journa Publication
3 Low-Dose blood pressure medicines combined